Journal
FUTURE MEDICINAL CHEMISTRY
Volume 15, Issue 15, Pages 1343-1368Publisher
Newlands Press Ltd
DOI: 10.4155/fmc-2023-0073
Keywords
alpha-amylase activity; alpha-glucosidase activity; in silico; in vitro; kinetic studies; pyridine
Categories
Ask authors/readers for more resources
In this study, a library of tetrahydropyridine (THP) compounds was synthesized and investigated for their potential as drug candidates for diabetes treatment. One compound with nitrophenyl substitution was identified as a strong inhibitor of α-glucosidase and α-amylase enzymes. Docking studies revealed its binding mechanism with the enzymes.
Researchers seeking new drug candidates to treat diabetes mellitus have been exploring bioactive molecules found in nature, particularly tetrahydropyridines (THPs). Methods: A library of THPs 1-31 was synthesized via a one-pot multicomponent reaction and investigated for their inhibition potential against a-glucosidase and a-amylase enzymes. Results: A nitrophenyl-substituted compound 5 with IC50 values of 0.15 +/- 0.01 and 1.10 +/- 0.04 mu M, and a K-m value of 1.30 mg/ml was identified as the most significant alpha-glucosidase and alpha-amylase inhibitor, respectively. Kinetic studies revealed the competitive mode of inhibition, and docking studies revealed that compound 5 binds to the enzyme by establishing hydrophobic and hydrophilic interactions and a salt bridge interaction with His279. Conclusion: These molecules may be a potential drug candidate for diabetes in the future.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available